-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, I7pkz8U7DbIEFzp2Oq/Z8Vs9bpyquDUzWHgEyJhUs7OL36UQLMnf3+3LdlyfwKDz YpR/rRJVq1JkPcJ3IiPV1A== 0001157523-09-005386.txt : 20090730 0001157523-09-005386.hdr.sgml : 20090730 20090730160217 ACCESSION NUMBER: 0001157523-09-005386 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090730 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20090730 DATE AS OF CHANGE: 20090730 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ULTRALIFE CORP CENTRAL INDEX KEY: 0000875657 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] IRS NUMBER: 161387013 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20852 FILM NUMBER: 09973785 BUSINESS ADDRESS: STREET 1: 2000 TECHNOLOGY PARKWAY CITY: NEWARK STATE: NY ZIP: 14513 BUSINESS PHONE: 3153327100 MAIL ADDRESS: STREET 1: 2000 TECHNOLOGY PARKWAY CITY: NEWARK STATE: NY ZIP: 14513 FORMER COMPANY: FORMER CONFORMED NAME: ULTRALIFE BATTERIES INC DATE OF NAME CHANGE: 19940224 8-K 1 a6019094.htm ULTRALIFE CORPORATION 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):

July 30, 2009


ULTRALIFE CORPORATION
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation or organization)

0-20852

16-1387013

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 


2000 Technology Parkway, Newark, New York       14513

(Address of principal executive offices)            (Zip Code)


(315) 332-7100
(Registrant’s telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 2.02. Results of Operations and Financial Condition.

Ultralife Corporation (the “Company”) reported results for the second quarter ended June 28, 2009.

Revenue for the second quarter was $39.6 million compared to $87.9 million for the same quarter last year, a $48.3 million decline attributable to lower advanced communications systems revenue. Revenue in the second quarter of 2008 included $61.9 million of advanced communications systems revenue related primarily to orders received in the latter part of 2007 that were fulfilled during 2008. Partially offsetting the lower advanced communications systems revenue was a $5.8 million increase in rechargeable products revenue and a $1.2 million increase in non-rechargeable products revenue. Gross margin for the second quarter declined to 17.1% from 23.5% for the comparable quarter last year, reflecting the lower contribution of higher margin advanced communications systems revenue. Included in the second quarter 2009 cost of products sold was a $1.8 million increase in the inventory reserve following the evaluation of lower of cost or market considerations as a result of current economic conditions.

The Company also revised its outlook for 2009 revenue and now expects 2009 fiscal year revenue to be between $180 million and $210 million and operating profit for the second half of the year to be between $1 million and $10 million.

The information set forth in this Form 8-K and the attached exhibit is being furnished to and not filed with the Securities and Exchange Commission and shall not be deemed to be incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing.

Item 9.01. Financial Statements, Pro Forma Financials and Exhibits.

(a)        Exhibits.

            99.1      Press Release dated July 30, 2009.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ULTRALIFE CORPORATION

Dated:

July 30, 2009.

By:

 

/s/John C. Casper

Vice President of Finance & CFO

 


INDEX TO EXHIBITS

(99)   Additional Exhibits

99.1   Press Release dated July 30, 2009.

EX-99.1 2 a6019094ex99_1.htm EXHIBIT 99.1

Exhibit 99.1

Ultralife Corporation Reports Second Quarter Results

NEWARK, N.Y.--(BUSINESS WIRE)--July 30, 2009--Ultralife Corporation (NASDAQ: ULBI) today reported results for the second quarter ended June 28, 2009.

Revenue for the second quarter was $39.6 million compared to $87.9 million for the same quarter last year, a $48.3 million decline attributable to lower advanced communications systems revenue. Revenue in the second quarter of 2008 included $61.9 million of advanced communications systems revenue related primarily to orders received in the latter part of 2007 that were fulfilled during 2008. Partially offsetting the lower advanced communications systems revenue was a $5.8 million increase in rechargeable products revenue and a $1.2 million increase in non-rechargeable products revenue. Gross margin for the second quarter declined to 17.1% from 23.5% for the comparable quarter last year, reflecting the lower contribution of higher margin advanced communications systems revenue. Included in the second quarter 2009 cost of products sold was a $1.8 million increase in the inventory reserve following the evaluation of lower of cost or market considerations as a result of current economic conditions.

Operating expenses for the second quarter of 2009 totaled $13.1 million compared to $10.7 million for the same quarter last year. The $2.4 million increase includes approximately $1.2 million of non-recurring expenses and the addition of the AMTI business acquired in March 2009. These non-recurring expenses include $0.7 million related to consolidation actions, including various severance payments, and $0.5 million of legal expenses related to the successful resolution of a litigation matter. Operating loss for the second quarter was $6.3 million compared to operating income of $9.9 million for the second quarter last year. Net loss for the second quarter was $7.0 million, or $0.41 per share, compared to net income for the second quarter of 2008 of $6.4 million, or $0.36 per share.

For the six-month period ended June 28, 2009, revenue was $79.4 million compared to $137.5 million for the same period a year ago. Operating loss amounted to $8.6 million compared to operating income of $12.3 million for the first half of 2008. Net loss for the first half of 2009 was $9.5 million, or $0.56 per share, compared to net income of $8.8 million, or $0.50 per share, for the same period a year ago.

“Ongoing delays in the release of government/defense orders have limited our revenue in the first half of 2009. In addition, our standby power business is performing below plan due to the economic downturn which has caused customers and prospects to defer capital spending and resulted in intense price competition,” said John D. Kavazanjian, president and chief executive officer. “These delays in order flow have put pressure on our operating profitability. In light of the first half of the year’s operating losses, we have cast a critical eye on the business, examining every facet of our operations, and identified various cost savings and efficiencies. As a result, we have taken actions to lower our manufacturing cost base and reduce current quarterly operating expenses by at least 10% to approximately $11 million by the end of the year. These actions are intended to drive operational improvements to become more efficient and realign our cost structure with current quarterly revenue levels.

“Although the orders for advanced communications systems have not yet come through, as the Government Furnished Equipment provider for the M-ATV and other programs, we continue to expect that we will receive some level of orders during the second half of the year,” concluded Kavazanjian. “Demand remains strong in our battery and communications products businesses and we are setting the stage for long-term growth through investments in more complex products and enhancements in our standby power services business while enforcing strict cost controls.”


Outlook

As a result of the delays in receiving government/defense orders, management has revised its outlook for 2009 revenue and now expects fiscal year revenue between $180 million and $210 million. Based on an estimate of revenue for the second half of the year between $100 million and $130 million, management expects operating profit for the second half of the year to range between $1 million and $10 million.

About Ultralife Corporation

Ultralife Corporation, which began as a battery company, now serves its markets with products and services ranging from portable and standby power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

Ultralife’s family of brands includes: Ultralife Batteries, Stationary Power Services, RPS Power Systems, ABLE, McDowell Research, RedBlack Communications and AMTI. Ultralife’s operations are in North America, Europe and Asia. For more information, visit www.ultralifecorp.com.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: worsening global economic conditions, increased competitive environment and pricing pressures, disruptions related to restructuring actions and delays. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company’s analysis only as of today’s date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife's financial results is included in Ultralife's Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.


ULTRALIFE CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In Thousands, Except Per Share Amounts)
(Unaudited)
                 
       
Three-Month Periods Ended Six-Month Periods Ended
 
June 28, June 28, June 28, June 28,

2009

2008

2009

2008

 
Revenues:
Non-rechargeable products $ 18,925 $ 17,699 $ 34,497 $ 32,315
Rechargeable products 10,307 4,490 24,161 11,228
Communications systems 6,601 61,946 10,837 86,000
Design and installation services   3,760     3,763     9,901     7,942  
Total revenues 39,593 87,898 79,396 137,485
 
Cost of products sold:
Non-rechargeable products 15,568 15,448 28,318 27,008
Rechargeable products 8,320 3,669 18,736 9,206
Communications systems 5,426 45,205 8,622 63,138
Design and installation services   3,499     2,948     9,159     6,630  
Total cost of products sold   32,813     67,270     64,835     105,982  
 
Gross margin 6,780 20,628 14,561 31,503
 
Operating expenses:
Research and development 2,514 2,137 4,494 3,746
Selling, general, and administrative   10,591     8,554     18,649     15,457  
Total operating expenses   13,105     10,691     23,143     19,203  
 
Operating income (loss) (6,325 ) 9,937 (8,582 ) 12,300
 
Other income (expense):
Interest income 1 2 4 13
Interest expense (350 ) (240 ) (532 ) (569 )
Gain on insurance settlement - - - 39
Gain on debt conversion - - - 313
Miscellaneous   (209 )   40     (198 )   109  
Income (loss) before income taxes   (6,883 )   9,739     (9,308 )   12,205  
 
Income tax provision-current - 264 2 318
Income tax provision-deferred   95     3,095     184     3,086  
Total income taxes   95     3,359     186     3,404  
 
Net income (loss) (6,978 ) 6,380 (9,494 ) 8,801
 
Net loss attributable to noncontrolling interest   14     15     18     28  
 
Net income (loss) attributable to Ultralife $ (6,964 ) $ 6,395   $ (9,476 ) $ 8,829  
 
 
Net income (loss) attributable to Ultralife common shareholders - basic $ (0.41 ) $ 0.37   $ (0.56 ) $ 0.51  
Net income (loss) attributable to Ultralife common shareholders - diluted $ (0.41 ) $ 0.36   $ (0.56 ) $ 0.50  
 
 
Weighted average shares outstanding - basic   16,894     17,309     17,024     17,155  
Weighted average shares outstanding - diluted   16,894     17,708     17,024     17,770  

ULTRALIFE CORPORATION
CONSOLIDATED BALANCE SHEETS
(In Thousands, Except Per Share Amounts)
(unaudited)
   
 
June 28, December 31,
ASSETS

2009

2008

 
Current assets:
Cash and investments $ 1,175 $ 1,878
Trade accounts receivable, net 30,587 30,588
Inventories 51,223 40,465
Prepaid expenses and other current assets   1,980     2,242  
Total current assets 84,965 75,173
 
Property and equipment 18,250 18,465
 
Other assets
Goodwill, intangible and other assets   39,448     35,949  
 
Total Assets $ 142,663   $ 129,587  
 
LIABILITIES AND SHAREHOLDERS' EQUITY
 
Current liabilities:
Short-term debt and current portion of long-term debt $ 24,514 $ 1,425
Accounts payable 20,449 20,255
Other current liabilities   10,790     10,556  
Total current liabilities   55,753     32,236  
 
Long-term liabilities:
Long-term debt and capital lease obligations 4,562 4,670
Other long-term liabilities   4,732     4,528  
Total long-term liabilities   9,294     9,198  
 
 
 
Shareholders' equity:
Ultralife equity:
Common stock, par value $0.10 per share 1,826 1,815
Capital in excess of par value 168,635 167,259
Accumulated other comprehensive income (loss) (1,057 ) (1,930 )
Accumulated deficit   (84,256 )   (74,780 )
85,148 92,364
Less -- Treasury stock, at cost   7,558     4,232  
Total Ultralife equity 77,590 88,132
Noncontrolling interest   26     21  
Total shareholders' equity   77,616     88,153  
 
Total Liabilities and Shareholders' Equity $ 142,663   $ 129,587  

CONTACT:
Company Contact:
Ultralife Corporation
John C. Casper, 315-332-7100
jcasper@ulbi.com
or
Investor Relations Contact:
Lippert/Heilshorn & Associates, Inc.
Jody Burfening, 212-838-3777
jburfening@lhai.com

-----END PRIVACY-ENHANCED MESSAGE-----